OREANDA-NEWS. August 19, 2014. The University of Tartu and India’s biggest medical technology company Trivitron Healthcare Pvt Ltd will sign a memorandum of understanding, forming the basis of a broad scientific cooperation and furthering of medical education between India and Estonia.

The cooperation will mainly be in areas related to mass spectrometry, microchips, sequencing, molecular diagnostics and biobanking. “The University of Tartu holds a leading position in the area of health care and medicine in Estonia and in the Baltic Sea region. The university’s competence and means for innovative research and development activities are the reasons which motivated the major Indian enterprise to cooperate with the University of Tartu,” said Erik Puura, Vice-Rector for Development of the University of Tartu.

The cooperation will begin after the partners have chosen common topics that are of interest to the researchers while also having commercial potential. “Our aim is to forge contacts between employees with similar interests to exchange the newest knowledge and develop solutions furthering people’s health,” commented Jane Luht, head of technology transfer at the University of Tartu, adding that exchange has already been initiated between four working groups.

The partners will also explore the opportunities to give the medical education of the University of Tartu in India, Dubai or Shanghai.

The Rector of the University of Tartu Professor Volli Kalm will sign the five-year memorandum of understanding with Gomathy SK Velu, the founder of Trivitron Healthcare Pvt Ltd company and the group, on 14 August at 12:00 at the Tallinn office of the University of Tartu. The Ambassador of India Aladiyan Manickam will also be (was also) present at the signing, as the development of scientific cooperation has been his special interest during his term of office.

Trivitron is India’s leading medical technology company, being the biggest manufacturer and marketer of equipment for in vitro diagnostics, imaging technology, intensive care and operating theatres and a leader in the development of ophthalmology, kidney transplantation and intensive care. The company operates globally in the name of innovation and cooperation to make health care available and affordable in developed as well as developing countries. The enterprise is focused on cost-effective solutions and services and cooperates actively with research and development institutions in the USA, India and Europe. It exports quality medical equipment to 165 countries, including the USA, European countries and Japan. Trivitron has branches in the United Arab Emirates, Sri Lanka, China and Finland.